Grifols, S.A.
NASDAQ: GRFS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Jose Ignacio Abia Buenache
- Employees
- 23,833
- Headquarters
- Barcelona, Spain
- IPO year
- 2011
- Market cap
- $6.3B
- Website
- https://www.grifols.com
Loading GRFS…
Loading profile data…Frequently asked questions about GRFS
What does Grifols, S.A. (GRFS) do?
Grifols, S.A., a company founded in 1940 and headquartered in Barcelona, Spain, specializes in the development, manufacture, and distribution of therapeutic products, with a primary focus on those derived from human plasma. Its operations are organized into several divisions. The Bioscience division is dedicated to researching, producing, and ma...
Where does GRFS trade?
Grifols, S.A. (GRFS) trades on the NASDAQ Global Select.
What sector is GRFS in?
Grifols, S.A. (GRFS) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Grifols, S.A.?
Jose Ignacio Abia Buenache is the chief executive officer of Grifols, S.A. (GRFS).
Where is Grifols, S.A. headquartered?
Grifols, S.A. is headquartered in Spain.
Does GRFS pay a dividend?
Yes — Grifols, S.A. (GRFS) paid a trailing twelve-month dividend of USD 0.18 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did GRFS go public?
Grifols, S.A. (GRFS) completed its initial public offering in 2011.
Is GRFS an ADR?
Yes — GRFS is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Grifols, S.A. reporting and dividends follow the underlying issuer.